Suppr超能文献

先天性甲状腺功能减退症的新生儿筛查与治疗进展

Update of newborn screening and therapy for congenital hypothyroidism.

作者信息

Rose Susan R, Brown Rosalind S, Foley Thomas, Kaplowitz Paul B, Kaye Celia I, Sundararajan Sumana, Varma Surendra K

出版信息

Pediatrics. 2006 Jun;117(6):2290-303. doi: 10.1542/peds.2006-0915.

Abstract

Unrecognized congenital hypothyroidism leads to mental retardation. Newborn screening and thyroid therapy started within 2 weeks of age can normalize cognitive development. The primary thyroid-stimulating hormone screening has become standard in many parts of the world. However, newborn thyroid screening is not yet universal in some countries. Initial dosage of 10 to 15 microg/kg levothyroxine is recommended. The goals of thyroid hormone therapy should be to maintain frequent evaluations of total thyroxine or free thyroxine in the upper half of the reference range during the first 3 years of life and to normalize the serum thyroid-stimulating hormone concentration to ensure optimal thyroid hormone dosage and compliance. Improvements in screening and therapy have led to improved developmental outcomes in adults with congenital hypothyroidism who are now in their 20s and 30s. Thyroid hormone regimens used today are more aggressive in targeting early correction of thyroid-stimulating hormone than were those used 20 or even 10 years ago. Thus, newborn infants with congenital hypothyroidism today may have an even better intellectual and neurologic prognosis. Efforts are ongoing to establish the optimal therapy that leads to maximum potential for normal development for infants with congenital hypothyroidism. Remaining controversy centers on infants whose abnormality in neonatal thyroid function is transient or mild and on optimal care of very low birth weight or preterm infants. Of note, thyroid-stimulating hormone is not elevated in central hypothyroidism. An algorithm is proposed for diagnosis and management. Physicians must not relinquish their clinical judgment and experience in the face of normal newborn thyroid test results. Hypothyroidism can be acquired after the newborn screening. When clinical symptoms and signs suggest hypothyroidism, regardless of newborn screening results, serum free thyroxine and thyroid-stimulating hormone determinations should be performed.

摘要

未被识别的先天性甲状腺功能减退会导致智力发育迟缓。新生儿筛查以及在出生后2周内开始甲状腺激素治疗可使认知发育正常化。原发性促甲状腺激素筛查已在世界许多地区成为标准。然而,新生儿甲状腺筛查在一些国家尚未普及。推荐左甲状腺素的初始剂量为10至15微克/千克。甲状腺激素治疗的目标应是在生命的前3年中频繁评估总甲状腺素或游离甲状腺素,使其保持在参考范围的上半部分,并使血清促甲状腺激素浓度正常化,以确保最佳的甲状腺激素剂量和依从性。筛查和治疗的改进已使现在二三十岁的先天性甲状腺功能减退成年患者的发育结局得到改善。与20年甚至10年前使用的甲状腺激素治疗方案相比,如今使用的方案在早期纠正促甲状腺激素方面更为积极。因此,如今患有先天性甲状腺功能减退的新生儿可能有更好的智力和神经预后。目前正在努力确定能使先天性甲状腺功能减退婴儿实现最大正常发育潜力的最佳治疗方法。尚存的争议集中在新生儿甲状腺功能异常为短暂性或轻度的婴儿,以及极低出生体重或早产儿的最佳护理上。值得注意的是,中枢性甲状腺功能减退时促甲状腺激素不升高。本文提出了一个诊断和管理的算法。面对新生儿甲状腺检查结果正常时,医生绝不能放弃其临床判断和经验。甲状腺功能减退可在新生儿筛查后获得。当临床症状和体征提示甲状腺功能减退时,无论新生儿筛查结果如何,均应进行血清游离甲状腺素和促甲状腺激素测定。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验